Pilot Trial of a Smartphone Smoking Cessation Application Intervention for Cancer Patients (Quit2Heal Study)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Fred Hutchinson Cancer Center
- Enrollment
- 59
- Locations
- 1
- Primary Endpoint
- 30-day point prevalence abstinence
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
The goal of this study is to determine whether the novel smartphone application designed specifically for cancer patients to quit smoking (Quit2Heal) provides higher quit rates than the current standard smoking cessation app.
Detailed Description
Cigarette smoking has harmful effects on cancer patients' treatment and prognosis, but there are systemic barriers to delivering smoking cessation interventions to cancer patients. One solution for addressing these barriers is to give patients immediate access to smoking cessation treatment via a smartphone application. The Quit2Heal smartphone app is engaging and tailored to the specific needs of cancer patients, and can be integrated into routine cancer care. The goal of this study is to determine whether Quit2Heal provides higher quit rates than the current standard smoking cessation app.
Investigators
Eligibility Criteria
Inclusion Criteria
- •age 18 or older
- •diagnosed with cancer in the past 12 months
- •has smoked a cigarette (even a puff) in the past 30 days
- •interested in learning skills to quit smoking
- •willing to be randomly assigned to either smartphone application
- •resides in US
- •has at least daily access to their own smartphone
- •knows how to login and download a smartphone application from the Apple app store or Android Play app store
- •willing and able to read in English
- •not currently using cessation medications or enrolled in other smoking cessation programs, and
Exclusion Criteria
- •The exclusion criteria are opposite of the inclusion criteria listed above.
Outcomes
Primary Outcomes
30-day point prevalence abstinence
Time Frame: 2 months post randomization
No smoking in the past 30 days, as reported 2 months post treatment.